Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?-Reference-Cited by-同舟云学术

Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?

Published:2019-02-11 Issue:4 Volume:28 Page:556-571
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Economics

Author:

Megiddo Itamar¹²^ORCID,Drabik Dusan³,Bedford Tim¹,Morton Alec¹^ORCID,Wesseler Justus³,Laxminarayan Ramanan¹²⁴

Affiliation:

1. Department of Management ScienceUniversity of Strathclyde Glasgow UK

2. Center for Disease Dynamics, Economics & Policy Washington DC

3. Agricultural Economics and Rural Policy GroupWageningen University Wageningen The Netherlands

4. Princeton Environmental InstitutePrinceton University Princeton New Jersey

Funder

Innovative Medicines Initiative

National Natural Science Foundation of China

Publisher

Wiley

Subject

Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.3867

Reference67 articles.

1. Antibiotic resistance and its cost: is it possible to reverse resistance?

2. Investment in antiviral drugs: a real options approach

3. Coexistence Rules and Regulations in the European Union

4. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness

5. Waves of resistance: Staphylococcus aureus in the antibiotic era

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic flexibility in healthcare: an exploration of real options;Journal of Economic Studies;2024-02-13

2. Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses;Journal of Economic Literature;2022-03-01

3. COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach;The European Journal of Health Economics;2022-01-11

4. Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?;Value in Health;2021-12

5. Macro-level efficiency of health expenditure: Estimates for 15 major economies;Social Science & Medicine;2021-10